Oramed Pharmaceuticals Inc. SEC filings ORMP
Oramed Pharmaceuticals Inc. has 941 filings in SEC EDGAR's recent list, going back to Nov 29, 2002. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Aug 3, 2026 | — |
| DEF 14A | Proxy statement | Aug 3, 2026 | Sep 15, 2026 |
| DEF 14A | Proxy statement | Jul 16, 2025 | Aug 19, 2025 |
| DEF 14A | Proxy statement | Jun 20, 2024 | Aug 1, 2024 |
| DEF 14A | Proxy statement | May 31, 2023 | Jul 13, 2023 |
| DEF 14A | Proxy statement | Jun 2, 2022 | Jun 30, 2022 |
| DEF 14A | Proxy statement | Jul 28, 2021 | Aug 30, 2021 |
| PRE 14A | Preliminary proxy statement | Jul 16, 2021 | Jul 16, 2021 |
| DEF 14A | Proxy statement | Jun 30, 2020 | Aug 3, 2020 |
| PRE 14A | Preliminary proxy statement | Jun 16, 2020 | Jun 16, 2020 |
| DEF 14A | Proxy statement | Aug 6, 2019 | Aug 29, 2019 |
| DEF 14A | Proxy statement | Jul 30, 2018 | Aug 28, 2018 |
| DEF 14A | Proxy statement | Aug 1, 2017 | Aug 30, 2017 |
| PRE 14A | Preliminary proxy statement | Jul 20, 2017 | Jul 20, 2017 |
| DEF 14A | Proxy statement | Aug 4, 2016 | Aug 30, 2016 |
| DEF 14A | Proxy statement | Jul 7, 2015 | Aug 11, 2015 |
| DEF 14A | Proxy statement | Jun 17, 2014 | Jun 17, 2014 |
| PRE 14A | Preliminary proxy statement | Jun 5, 2014 | Jun 5, 2014 |
| DEF 14A | Proxy statement | Jul 3, 2012 | Jul 3, 2012 |
| PRE 14A | Preliminary proxy statement | Jun 7, 2012 | Jun 7, 2012 |
| DEF 14A | Proxy statement | Jan 31, 2011 | Feb 24, 2011 |
| PRE 14A | Preliminary proxy statement | Jan 4, 2011 | Mar 1, 2011 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORMP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1176309
- Former names
- Integrated Security Technologies, Inc. (until Apr 10, 2006); IGUANA VENTURES LTD (until Jun 10, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.